enGene Therapeutics Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
7.91
+0.30 (3.94%)
At close: May 5, 2026, 4:00 PM EDT
7.89
-0.02 (-0.25%)
After-hours: May 5, 2026, 4:10 PM EDT
enGene Therapeutics Employees
As of October 31, 2025, enGene Therapeutics had 82 total employees, including 81 full-time and 1 part-time employees. The number of employees increased by 25 or 43.86% compared to the previous year.
Employees
82
Change (1Y)
25
Growth (1Y)
43.86%
Revenue / Employee
n/a
Profits / Employee
-$1,493,146
Market Cap
529.89M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Oct 31, 2025 | 82 | 25 | 43.86% | 81 | 1 |
| Oct 31, 2024 | 57 | 24 | 72.73% | 56 | 1 |
| Oct 31, 2023 | 33 | - | - | 31 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 674 |
| Verastem | 102 |
| Upstream Bio | 75 |
| Contineum Therapeutics | 51 |
| Eupraxia Pharmaceuticals | 49 |
| Zura Bio | 40 |
| Shattuck Labs | 40 |
| Ovid Therapeutics | 23 |
ENGN News
- 4 weeks ago - enGene Announces Name Change to enGene Therapeutics Inc. - Business Wire
- 7 weeks ago - enGene Therapeutics Transcript: The Citizens Life Sciences Conference 2026 - Transcripts
- 2 months ago - enGene Therapeutics Transcript: Barclays 28th Annual Global Healthcare Conference - Transcripts
- 2 months ago - enGene Therapeutics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - enGene Reports First Quarter 2026 Financial Results and Provides Business Update - Business Wire
- 2 months ago - enGene Therapeutics Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference - Transcripts
- 2 months ago - enGene to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - enGene Therapeutics Transcript: Guggenheim Securities Emerging Outlook: Biotech Summit 2026 - Transcripts